V
Viking Therapeutics (VKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Viking Therapeutics (VKTX)
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which i... Read more
- USD27.97
- USD28.73
- USD27.45
- USD81.73
- 19.30%
- --
- 24.60k
- 4.36M
- 3.3B
- 18.92
- -65.60%
Stock News
57 minutes ago
How Bessent explained the 115-point reduction in U.S.-China tariffs that has triggered market euphoria
MarketWatch
5 hours ago
The 1-Minute Market Report - May 11, 2025
SeekingAlpha
5 hours ago
YYY: Stretching For An Amplified Yield Of 12.8%
SeekingAlpha
6 hours ago
US Foods: Margin Expansion Priced In, Initiate At Hold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
